| Bask Psychological Services | |
|
1516 S Langley Dr Florence SC 29501-6149 | |
| (843) 621-0263 | |
| (843) 536-8522 |
| Full Name | Bask Psychological Services |
|---|---|
| Speciality | Psychologist |
| Location | 1516 S Langley Dr, Florence, South Carolina |
| Authorized Official Name and Position | Alexis Sanders (LICENSED CLINICAL PSYCHOLOGIST) |
| Authorized Official Contact | 8436210263 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bask Psychological Services 1516 S Langley Dr Florence SC 29501-6149 Ph: (843) 621-0263 | Bask Psychological Services 1516 S Langley Dr Florence SC 29501-6149 Ph: (843) 621-0263 |
| NPI Number | 1134683006 |
|---|---|
| Provider Enumeration Date | 01/24/2019 |
| Last Update Date | 06/09/2020 |
| Certification Date | 06/09/2020 |
| Medicare PECOS PAC ID | 9739428681 |
|---|---|
| Medicare Enrollment ID | O20190311002850 |
News Archive
Life Technologies Corporation today announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, on the Ion Personal Genome Machine strongly suggests that the bacterium at the root of the deadly outbreak in Germany is a new hybrid type of pathogenic E. coli strains.
Bacterial pathogens pose serious health risks, especially for infants, young children, elderly and those with compromised immune systems.
LEO Pharma announces it has submitted a New Drug Application (NDA) for calcipotriene and betamethasone dipropionate aerosol foam, 0.005%/0.064%, to the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis.
Regeneron Pharmaceuticals, Inc. today announced that the Company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEA (aflibercept) Injection.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134683006 | NPI | - | NPPES |
| PS5060 | Medicaid | SC |
| Provider Name | Alexis Yvonne Sanders |
|---|---|
| Provider Type | Practitioner - Psychologist Billing Independently |
| Provider Identifiers | NPI Number: 1851547335 PECOS PAC ID: 5698099364 Enrollment ID: I20150129000777 |
News Archive
Life Technologies Corporation today announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, on the Ion Personal Genome Machine strongly suggests that the bacterium at the root of the deadly outbreak in Germany is a new hybrid type of pathogenic E. coli strains.
Bacterial pathogens pose serious health risks, especially for infants, young children, elderly and those with compromised immune systems.
LEO Pharma announces it has submitted a New Drug Application (NDA) for calcipotriene and betamethasone dipropionate aerosol foam, 0.005%/0.064%, to the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis.
Regeneron Pharmaceuticals, Inc. today announced that the Company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEA (aflibercept) Injection.
› Verified 9 days ago
News Archive
Life Technologies Corporation today announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, on the Ion Personal Genome Machine strongly suggests that the bacterium at the root of the deadly outbreak in Germany is a new hybrid type of pathogenic E. coli strains.
Bacterial pathogens pose serious health risks, especially for infants, young children, elderly and those with compromised immune systems.
LEO Pharma announces it has submitted a New Drug Application (NDA) for calcipotriene and betamethasone dipropionate aerosol foam, 0.005%/0.064%, to the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis.
Regeneron Pharmaceuticals, Inc. today announced that the Company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEA (aflibercept) Injection.
› Verified 9 days ago
Janet D. Woolery,m.d., Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 520 W Palmetto St, Florence, SC 29501 Phone: 843-667-6226 Fax: 843-667-6224 | |
Aba Depot Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 800 E Cheves St Ste 280, Florence, SC 29506 Phone: 843-799-0076 Fax: 800-557-0208 | |
Assure Behavioral Health Services Of South Carolina Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 212 Mcleod Aly, Florence, SC 29501 Phone: 252-933-7203 | |
Nu-start & Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601a W Lucas St, Florence, SC 29501 Phone: 843-453-6071 Fax: 843-665-8809 | |
Florence Schools District One Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1901 E Old Marion Hwy, Florence, SC 29506 Phone: 843-678-4193 Fax: 843-664-8180 | |
Pee Dee Mental Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 125 E Cheves St, Florence, SC 29506 Phone: 843-317-4089 | |
Amethyst Wellness Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1001 West Even Street, Florence, SC 29501 Phone: 980-316-5129 |